4,7-Dibromo-2,1,3-benzothiadiazole>98.0%(GC)1g

1-cyclopropanecarbonyl-3-methylpiperazine, 95.0%, 2g

Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate (2S,3S)-2,3-bis(benzoyloxy)succinate, 97%, 250mg

4-Bromo-2-methyl-1-nitrobenzene, 98.0%, 100g

5-(2-Methyl-1,3-thiazol-4-yl)thiophene-2-carboxylic acid, 97%, 5g

2-Methoxyphenylacetic Acid>98.0%(GC)(T)5g

1-Isopropylazetidin-3-ol hydrochloride, 95.0%, 10g

1-(4-Chlorophenyl)-5-methyl-1h-pyrazole-3-carboxylic acid, 95+%, 100mg

Serological pipettes CELLSTAR®, 5 ml, 4 x (50 x 1), 200 pieces

4-bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile, 95.0%, 25g

Phenylpiracetam>98.0%(HPLC)(N)1g

(S)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester, 95.0%, 500g

(3S,6R)-1-(6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl)-N-cyclohexyl-6-methylpiperidine-3-carboxamide, 98%, 5mg